Dr. Vipul Gujrati

Dr. Vipul Gujrati leads a research group at the Institute of Biological and Medical Imaging (IBMI) at Helmholtz Munich, Germany. His work focuses on the development of advanced nanoagents for biomedical imaging and targeted drug delivery, with a strong emphasis on optoacoustic imaging and theranostics.

He began his postdoctoral research under the mentorship of Professor Vasilis Ntziachristos, a global leader in optoacoustic imaging. Over the past five years, Dr. Gujrati has led multiple research initiatives, including projects funded by the European Commission’s Horizon 2020 program, and has mentored several graduate students.

Dr. Gujrati earned his Ph.D. in Biological Sciences from the Korea Advanced Institute of Science and Technology (KAIST), South Korea, where he specialized in biomaterials and synthetic materials for imaging and therapeutic applications. He also holds a Master’s degree in Pharmacology and Toxicology from Rajiv Gandhi University of Health Sciences (RGUHS), Karnataka, India, and a Bachelor’s degree in Pharmacy from the University of Pune, Maharashtra, India.

His interdisciplinary research spans biomaterials, cell and gene therapy, drug and vaccine delivery, material science, biophotonics, and optoacoustic imaging. His work has been published in high-impact journals and has contributed to significant advancements in these fields.

Dr. Gujrati has received several honors for his scientific contributions, including the Scientific Excellence Award from CBI-IBMI in 2019 and the Best Thesis Award (Gold Medal) from KAIST in 2014 for his pioneering work on nanomaterials for cancer imaging and therapy.